Dark

FENC
Fennec Pharmaceuticals Inc. Common Stock
stock NASDAQ

At Close

Dec 29, 2025 3:59:58 PM EST

7.68USD-5.068%(-0.41)193,137

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 29, 2025 9:25:30 AM EST

8.08USD-0.124%(-0.01)198

After-hours

Dec 26, 2025 4:00:30 PM EST

8.09USD+0.497%(+0.04)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

262.30M

CEO

Rostislav Raykov

Headquarters

Durham, North Carolina, USA

Industry

Biotechnology

Next Earnings

Apr 1, 2026 (91d)

Last Split

Aug 30, 20111for17.9986reverse

AMGN GSK BMY JNJ LLY PFE SNY INSY XLV

FENC Stats

Avg. Vol. 10 Day

259,982

Avg. Vol. 30 Day

219,458

Market Cap

262,298,849

Shares Out.

34,153,496

On/Off Exchange

42%/58%

6 Month Beta

1.52

1 Year Beta

0.82

2 Year Beta

0.86

3 Year Beta

0.82

52 Week Low

4.68

52 Week High

9.92

SMA50

8.03

SMA200

7.82

1 Week

-0.13%

1 Month

-6.23%

3 Month

-15.51%

6 Month

-7.47%

1 Year

+24.68%

2 Year

-31.55%

5 Year

+8.32%

Profile

fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states. its lead product pedmark, a formulation of sodium thiosulfate, which has completed the phase iii clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. the company was formerly known as adherex technologies inc. and changed its name to fennec pharmaceuticals inc. in september 2014. fennec pharmaceuticals inc. was founded in 1996 and is based in research triangle park, north carolina.

FENC Stock Summary

Fennec Pharmaceuticals Inc. Common Stock (NASDAQ:FENC) stock price today is $7.68, and today's volume is 193,137. FENC is down -5.068% today. The 30 day average volume is 219,458. FENC market cap is 262.30M with 34,153,496 shares outstanding.